Bafna Pharmaceuticals launches RARICAP injection in domestic market

20 Nov 2013 Evaluate

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched RARICAP in injection form as RARICAP S in domestic market. This is another product in women wellness segment for Iron Deficiency Anaemia during Pregnancy and also for Anaemia in Chronic Kidney Disease.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

107.95 -3.85 (-3.44%)
09-Mar-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1809.40
Dr. Reddys Lab 1288.40
Cipla 1327.85
Zydus Lifesciences 908.30
Lupin 2303.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×